SlideShare a Scribd company logo
1 of 13
CIRCOVAC   piglet efficacy Laurent Fischer, DVM , PhD Director, Senior Technical Leader R&D, Project and Portfolio Management   - MERIAL
CIRCOVAC piglet efficacy ,[object Object],[object Object],[object Object],[object Object]
CIRCOVAC: characteristics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Piglet indications     Lesions and virus load in lymphoid tissues     Faecal excretion     Virus load     weight loss     mortality     wasting     Clinical signs Active immunisation
Active immunisation Chevalier  et al,  Proceedings of the 21 st  IPVS Congress, Vancouver, Canada, 2010, p 439 Dossier A.M.M. CIRCOVAC. N°08.609 CIRCOVAC piglets vaccination induces seroneutralizing antibodies:  quick onset and high titres  D0 = Vaccination
Virus load decreased ,[object Object],Significant less pigs positive for viremia and the mean viral load was significantly decreased in the CIRCOVAC vaccinated group  Chevalier  et al ,  Proceedings of the 21 st  IPVS Congress, Vancouver, Canada, 2010, p 437 Expérimental conditions * p<0,0001 * * * D0 = Challenge D0 = Vaccination
Faecal excretion reduced Dossier A.M.M. CIRCOVAC. N° 08.0032.P * * *Student t test p<0,0001 D0  =  Vaccination
Lymphoid lesions reduced Dossier A.M.M. CIRCOVAC. N° 08.0610.R *Fisher test p<0,001 No lesion 80 % lesions Control
Virus load reduced  Dossier A.M.M. CIRCOVAC. N° 08.0610.R Virus load (IHC) of mesenteric lymph nodes Control Photo: Pr Sarli *Fisher test p<0,001
Lymphoid lesions reduced *Student t test p<0,05 Dossier A.M.M. CIRCOVAC. N° 08.0338.R *  Weight (g) of lymph nodes *  Control CIRCOVAC
Lymphoid lesions reduced Control
CIRCOVAC piglets vaccination is efficient ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Thank you!

More Related Content

What's hot

OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
EuFMD
 
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
EuFMD
 
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
EuFMD
 
OS20 - Characterising foot-and-mouth disease virus in clinical samples using ...
OS20 - Characterising foot-and-mouth disease virus in clinical samples using ...OS20 - Characterising foot-and-mouth disease virus in clinical samples using ...
OS20 - Characterising foot-and-mouth disease virus in clinical samples using ...
EuFMD
 
OS20 - Diagnostic performance of foot-and-mouth disease virus detection and s...
OS20 - Diagnostic performance of foot-and-mouth disease virus detection and s...OS20 - Diagnostic performance of foot-and-mouth disease virus detection and s...
OS20 - Diagnostic performance of foot-and-mouth disease virus detection and s...
EuFMD
 
Study Tour Presentation, Istituto Superiore di Sanità, Roma, October 2007, Gl...
Study Tour Presentation, Istituto Superiore di Sanità, Roma, October 2007, Gl...Study Tour Presentation, Istituto Superiore di Sanità, Roma, October 2007, Gl...
Study Tour Presentation, Istituto Superiore di Sanità, Roma, October 2007, Gl...
Sasa Jankovic
 

What's hot (19)

OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
OS20 - Filtration assisted luminometric ELISA (FAL-ELISA) applied to the dete...
 
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
 
Bacterial Display Technology - Creative Biolabs
Bacterial Display Technology - Creative BiolabsBacterial Display Technology - Creative Biolabs
Bacterial Display Technology - Creative Biolabs
 
Adenovirus service
Adenovirus serviceAdenovirus service
Adenovirus service
 
baculovirus expression
baculovirus expression baculovirus expression
baculovirus expression
 
Adenovirus Services
Adenovirus ServicesAdenovirus Services
Adenovirus Services
 
Adenovirus service
Adenovirus serviceAdenovirus service
Adenovirus service
 
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
 
OS20 - Characterising foot-and-mouth disease virus in clinical samples using ...
OS20 - Characterising foot-and-mouth disease virus in clinical samples using ...OS20 - Characterising foot-and-mouth disease virus in clinical samples using ...
OS20 - Characterising foot-and-mouth disease virus in clinical samples using ...
 
Yeast Display Technology - Creative Biolabs
Yeast Display Technology - Creative BiolabsYeast Display Technology - Creative Biolabs
Yeast Display Technology - Creative Biolabs
 
OS20 - Diagnostic performance of foot-and-mouth disease virus detection and s...
OS20 - Diagnostic performance of foot-and-mouth disease virus detection and s...OS20 - Diagnostic performance of foot-and-mouth disease virus detection and s...
OS20 - Diagnostic performance of foot-and-mouth disease virus detection and s...
 
The Flu Virus In An Aerosol Droplet
The Flu Virus In An Aerosol DropletThe Flu Virus In An Aerosol Droplet
The Flu Virus In An Aerosol Droplet
 
Study Tour Presentation, Istituto Superiore di Sanità, Roma, October 2007, Gl...
Study Tour Presentation, Istituto Superiore di Sanità, Roma, October 2007, Gl...Study Tour Presentation, Istituto Superiore di Sanità, Roma, October 2007, Gl...
Study Tour Presentation, Istituto Superiore di Sanità, Roma, October 2007, Gl...
 
Natural enemies of Sugarcane Aphid
Natural enemies of Sugarcane AphidNatural enemies of Sugarcane Aphid
Natural enemies of Sugarcane Aphid
 
Selection of tomato plants resistant to a local TSWV strain
Selection of tomato plants resistant to a local TSWV strainSelection of tomato plants resistant to a local TSWV strain
Selection of tomato plants resistant to a local TSWV strain
 
SARS-CoV-2 testing: methods and problems
SARS-CoV-2 testing: methods and problemsSARS-CoV-2 testing: methods and problems
SARS-CoV-2 testing: methods and problems
 
Hendra inside2
Hendra inside2Hendra inside2
Hendra inside2
 
Global germplasm collections: sure benefits without seedborne diseases
Global germplasm collections: sure benefits without seedborne diseasesGlobal germplasm collections: sure benefits without seedborne diseases
Global germplasm collections: sure benefits without seedborne diseases
 
Session 1: Strengthening border biosecurity Improving - Post Entry Quarantine...
Session 1: Strengthening border biosecurity Improving - Post Entry Quarantine...Session 1: Strengthening border biosecurity Improving - Post Entry Quarantine...
Session 1: Strengthening border biosecurity Improving - Post Entry Quarantine...
 

Similar to 02 laurent fischer

9_Fraser_VAP_Hopkins_Fellows_Course-converted.pptx
9_Fraser_VAP_Hopkins_Fellows_Course-converted.pptx9_Fraser_VAP_Hopkins_Fellows_Course-converted.pptx
9_Fraser_VAP_Hopkins_Fellows_Course-converted.pptx
aceforum
 
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...
HK HuZef
 

Similar to 02 laurent fischer (20)

Viral loaded six month Industrial training.pptx
Viral loaded six month Industrial training.pptxViral loaded six month Industrial training.pptx
Viral loaded six month Industrial training.pptx
 
ICAAC 2014: Selection of sessions and abstracts
ICAAC 2014: Selection of sessions and abstractsICAAC 2014: Selection of sessions and abstracts
ICAAC 2014: Selection of sessions and abstracts
 
CDC dec 2015 - Strengthening a Culture of Laboratory Safety
CDC dec 2015 - Strengthening a Culture of Laboratory SafetyCDC dec 2015 - Strengthening a Culture of Laboratory Safety
CDC dec 2015 - Strengthening a Culture of Laboratory Safety
 
9_Fraser_VAP_Hopkins_Fellows_Course-converted.pptx
9_Fraser_VAP_Hopkins_Fellows_Course-converted.pptx9_Fraser_VAP_Hopkins_Fellows_Course-converted.pptx
9_Fraser_VAP_Hopkins_Fellows_Course-converted.pptx
 
Nat testing
Nat testingNat testing
Nat testing
 
AIDS.pptx
AIDS.pptxAIDS.pptx
AIDS.pptx
 
Covid19 emerging data and guidance
Covid19 emerging data and guidanceCovid19 emerging data and guidance
Covid19 emerging data and guidance
 
Care start access bio antigen test covid 19 biotechh commerce
Care start access bio antigen test covid 19 biotechh commerceCare start access bio antigen test covid 19 biotechh commerce
Care start access bio antigen test covid 19 biotechh commerce
 
Change of neurosurgical planning during COVID-19 pandemic and endemic era
Change of neurosurgical planning during COVID-19 pandemic and endemic eraChange of neurosurgical planning during COVID-19 pandemic and endemic era
Change of neurosurgical planning during COVID-19 pandemic and endemic era
 
COMPARISON OF 3 PRODUCTION SYSTEMS FOR VACCINE MANUFACTURING
COMPARISON OF 3 PRODUCTION SYSTEMS FOR VACCINE MANUFACTURINGCOMPARISON OF 3 PRODUCTION SYSTEMS FOR VACCINE MANUFACTURING
COMPARISON OF 3 PRODUCTION SYSTEMS FOR VACCINE MANUFACTURING
 
EUA-Sansure-kit-ifu-v2.pdf
EUA-Sansure-kit-ifu-v2.pdfEUA-Sansure-kit-ifu-v2.pdf
EUA-Sansure-kit-ifu-v2.pdf
 
Infection control in the ICU
Infection control in the ICUInfection control in the ICU
Infection control in the ICU
 
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...
 
COVID PPT.pptx
COVID PPT.pptxCOVID PPT.pptx
COVID PPT.pptx
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
 
Catheter Associated Urinary Tract Infection (CAUTI)
Catheter Associated Urinary Tract Infection (CAUTI)Catheter Associated Urinary Tract Infection (CAUTI)
Catheter Associated Urinary Tract Infection (CAUTI)
 
Highlights of AIDS 2016
Highlights of AIDS 2016Highlights of AIDS 2016
Highlights of AIDS 2016
 
approaching infection outbreak in picu
approaching infection outbreak in picuapproaching infection outbreak in picu
approaching infection outbreak in picu
 
OS16 - 3.1.a The Origin, Evolution and Diagnosis of Seneca Valley Virus, A ...
OS16 - 3.1.a   The Origin, Evolution and Diagnosis of Seneca Valley Virus, A ...OS16 - 3.1.a   The Origin, Evolution and Diagnosis of Seneca Valley Virus, A ...
OS16 - 3.1.a The Origin, Evolution and Diagnosis of Seneca Valley Virus, A ...
 
Diarrhea escmid shea course
Diarrhea escmid shea courseDiarrhea escmid shea course
Diarrhea escmid shea course
 

More from Merial EMEA

Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigApvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Merial EMEA
 
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Merial EMEA
 
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Merial EMEA
 
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Merial EMEA
 
Apvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationApvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculation
Merial EMEA
 
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaApvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Merial EMEA
 
Apvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonApvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparison
Merial EMEA
 
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Merial EMEA
 
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Merial EMEA
 
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyApvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Merial EMEA
 
Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...
Merial EMEA
 
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterAasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Merial EMEA
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Merial EMEA
 

More from Merial EMEA (20)

VAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialVAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - Merial
 
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialVAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
 
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialVAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
 
VAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialVAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - Merial
 
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialVAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
 
VAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialVAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - Merial
 
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigApvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
 
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
 
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
 
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
 
Apvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationApvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculation
 
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaApvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
 
Apvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonApvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparison
 
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
 
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
 
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyApvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
 
Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...
 
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterAasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
 
ESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL MomentumESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL Momentum
 

Recently uploaded

Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Recently uploaded (20)

Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 

02 laurent fischer

  • 1. CIRCOVAC  piglet efficacy Laurent Fischer, DVM , PhD Director, Senior Technical Leader R&D, Project and Portfolio Management - MERIAL
  • 2.
  • 3.
  • 4. Piglet indications   Lesions and virus load in lymphoid tissues   Faecal excretion   Virus load   weight loss   mortality   wasting   Clinical signs Active immunisation
  • 5. Active immunisation Chevalier et al, Proceedings of the 21 st IPVS Congress, Vancouver, Canada, 2010, p 439 Dossier A.M.M. CIRCOVAC. N°08.609 CIRCOVAC piglets vaccination induces seroneutralizing antibodies: quick onset and high titres D0 = Vaccination
  • 6.
  • 7. Faecal excretion reduced Dossier A.M.M. CIRCOVAC. N° 08.0032.P * * *Student t test p<0,0001 D0 = Vaccination
  • 8. Lymphoid lesions reduced Dossier A.M.M. CIRCOVAC. N° 08.0610.R *Fisher test p<0,001 No lesion 80 % lesions Control
  • 9. Virus load reduced Dossier A.M.M. CIRCOVAC. N° 08.0610.R Virus load (IHC) of mesenteric lymph nodes Control Photo: Pr Sarli *Fisher test p<0,001
  • 10. Lymphoid lesions reduced *Student t test p<0,05 Dossier A.M.M. CIRCOVAC. N° 08.0338.R * Weight (g) of lymph nodes * Control CIRCOVAC
  • 12.

Editor's Notes

  1. N = 3 témoins et 8 vaccinés Vaccinés à 3 sm d’âge Porcelets SPF Tous ont séroconvertit sauf un porcelet! Immunité protectrice à + 2 sm post vaccination (dans le dossier)
  2. Station :étude durée d’immunité: vaccination des porcelets à 3 semaines d’âge 14 semaines avant le challenge N = 12 témoins et 15 vaccinés Vaccinés à 3 sm d’âge Porcelets SPF Challenge intra nasal à 17 semaines d’âge: 2*5 ml de suspension Espagne : Exploitation espagnole avec historique de pcv2 avec mortalité sevrage-vente : 10 à 15 % 1239 porcelets inclus (619 Circovac et 620 témoins négatifs) Les résultats présentés sont ceux du site A ( et sont identiques avec le site B) 56 porcs prélevés vaccinés et 51 porcs témoin prélevés pour recherche qPCR PCV2 Pas mixés pendant l’étude Pourquoi arrêt à 140 jours + 21 jours d’âge = 161?? Lparce que es analyses de virémie n’étaient pas prévu dans le protocole de l’élevage A avant l’abattage. Elles ont par contre été réalisées dans l’élevage B avant abattage (l’âge n’est pas précisé, minimum 168 jours d’âge en tout cas et de toute façon, les données de cet élevage B montre une différence jusqu’à l’abattage pour la virémie en faveur du lot vacciné mais pas pour l’excrétion fécale qui est supérieur dans le lot vacciné au lot témoin juste avant abattage…)
  3. Même exploitation que diapo précédente Fecal samples collected from the same animals: 56 vaccinated pigs and 51 control pigs Control group: 98% positive pig at D98 versus 33% in vaccinated group
  4. 15 vaccinés 15 control D0= date de vaccination (3 sem d’âge) D21= date de challenge D49= euthanasie (1 mois après challenge)
  5. N = 15 porcelets vaccinés et 15 témoins
  6. N = 15 vaccinés et 15 témoins négatifs Vaccinés à 3 sm d’âge puis challengés à 5 sm d’âge Porcelets SPF